Inspira Technologies Oxy BHN (IINN) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Inspira Technologies Oxy BHN Ltd., a pioneering medical technology firm, has announced the Israeli Ministry of Health’s approval for its innovative INSPIRA ART100 system, following FDA clearance. This approval is seen as a critical step in the company’s global business development plans, which include expanding into new markets beyond the U.S. The ART100 system offers advanced life support technology, aiming to improve patient treatment by allowing for oxygenation without the need for intubation.
For further insights into IINN stock, check out TipRanks’ Stock Analysis page.